631 related articles for article (PubMed ID: 10864893)
1. Sensitivity of Kir6.2-SUR1 currents, in the absence and presence of sodium azide, to the K(ATP) channel inhibitors, ciclazindol and englitazone.
McKay NG; Kinsella JM; Campbell CM; Ashford ML
Br J Pharmacol; 2000 Jun; 130(4):857-66. PubMed ID: 10864893
[TBL] [Abstract][Full Text] [Related]
2. Diazoxide- and leptin-activated K(ATP) currents exhibit differential sensitivity to englitazone and ciclazindol in the rat CRI-G1 insulin-secreting cell line.
Harvey J; Ashford ML
Br J Pharmacol; 1998 Aug; 124(7):1557-65. PubMed ID: 9723971
[TBL] [Abstract][Full Text] [Related]
3. Tissue specificity of sulfonylureas: studies on cloned cardiac and beta-cell K(ATP) channels.
Gribble FM; Tucker SJ; Seino S; Ashcroft FM
Diabetes; 1998 Sep; 47(9):1412-8. PubMed ID: 9726229
[TBL] [Abstract][Full Text] [Related]
4. Involvement of the n-terminus of Kir6.2 in coupling to the sulphonylurea receptor.
Reimann F; Tucker SJ; Proks P; Ashcroft FM
J Physiol; 1999 Jul; 518 ( Pt 2)(Pt 2):325-36. PubMed ID: 10381582
[TBL] [Abstract][Full Text] [Related]
5. Effects of mitiglinide (S 21403) on Kir6.2/SUR1, Kir6.2/SUR2A and Kir6.2/SUR2B types of ATP-sensitive potassium channel.
Reimann F; Proks P; Ashcroft FM
Br J Pharmacol; 2001 Apr; 132(7):1542-8. PubMed ID: 11264248
[TBL] [Abstract][Full Text] [Related]
6. Properties of cloned ATP-sensitive K+ currents expressed in Xenopus oocytes.
Gribble FM; Ashfield R; Ammälä C; Ashcroft FM
J Physiol; 1997 Jan; 498 ( Pt 1)(Pt 1):87-98. PubMed ID: 9023770
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the differential modulation of sulphonylurea block of beta-cell and cardiac ATP-sensitive K+ (K(ATP)) channels by Mg-nucleotides.
Reimann F; Dabrowski M; Jones P; Gribble FM; Ashcroft FM
J Physiol; 2003 Feb; 547(Pt 1):159-68. PubMed ID: 12562963
[TBL] [Abstract][Full Text] [Related]
8. Taurine block of cloned ATP-sensitive K+ channels with different sulfonylurea receptor subunits expressed in Xenopus laevis oocytes.
Lim JG; Lee HY; Yun JE; Kim SP; Park JW; Suh SI; Jang BC; Cho CH; Bae JH; Kim SS; Han J; Park MJ; Song DK
Biochem Pharmacol; 2004 Sep; 68(5):901-10. PubMed ID: 15294453
[TBL] [Abstract][Full Text] [Related]
9. Different molecular sites of action for the KATP channel inhibitors, PNU-99963 and PNU-37883A.
Cui Y; Tinker A; Clapp LH
Br J Pharmacol; 2003 May; 139(1):122-8. PubMed ID: 12746230
[TBL] [Abstract][Full Text] [Related]
10. The effects of mitiglinide (KAD-1229), a new anti-diabetic drug, on ATP-sensitive K+ channels and insulin secretion: comparison with the sulfonylureas and nateglinide.
Sunaga Y; Gonoi T; Shibasaki T; Ichikawa K; Kusama H; Yano H; Seino S
Eur J Pharmacol; 2001 Nov; 431(1):119-25. PubMed ID: 11716850
[TBL] [Abstract][Full Text] [Related]
11. Pharmacology of human sulphonylurea receptor SUR1 and inward rectifier K(+) channel Kir6.2 combination expressed in HEK-293 cells.
Gopalakrishnan M; Molinari EJ; Shieh CC; Monteggia LM; Roch JM; Whiteaker KL; Scott VE; Sullivan JP; Brioni JD
Br J Pharmacol; 2000 Apr; 129(7):1323-32. PubMed ID: 10742287
[TBL] [Abstract][Full Text] [Related]
12. Sulfonylurea receptors type 1 and 2A randomly assemble to form heteromeric KATP channels of mixed subunit composition.
Chan KW; Wheeler A; Csanády L
J Gen Physiol; 2008 Jan; 131(1):43-58. PubMed ID: 18079561
[TBL] [Abstract][Full Text] [Related]
13. Functional coupling between sulfonylurea receptor type 1 and a nonselective cation channel in reactive astrocytes from adult rat brain.
Chen M; Dong Y; Simard JM
J Neurosci; 2003 Sep; 23(24):8568-77. PubMed ID: 13679426
[TBL] [Abstract][Full Text] [Related]
14. Altered functional properties of KATP channel conferred by a novel splice variant of SUR1.
Sakura H; Trapp S; Liss B; Ashcroft FM
J Physiol; 1999 Dec; 521 Pt 2(Pt 2):337-50. PubMed ID: 10581306
[TBL] [Abstract][Full Text] [Related]
15. Identification of the high-affinity tolbutamide site on the SUR1 subunit of the K(ATP) channel.
Ashfield R; Gribble FM; Ashcroft SJ; Ashcroft FM
Diabetes; 1999 Jun; 48(6):1341-7. PubMed ID: 10342826
[TBL] [Abstract][Full Text] [Related]
16. MCC-134, a novel vascular relaxing agent, is an inverse agonist for the pancreatic-type ATP-sensitive K(+) channel.
Shindo T; Katayama Y; Horio Y; Kurachi Y
J Pharmacol Exp Ther; 2000 Jan; 292(1):131-5. PubMed ID: 10604939
[TBL] [Abstract][Full Text] [Related]
17. Effect of englitazone on KATP and calcium-activated non-selective cation channels in CRI-G1 insulin-secreting cells.
Rowe IC; Lee K; Khan RN; Ashford ML
Br J Pharmacol; 1997 Jun; 121(3):531-9. PubMed ID: 9179397
[TBL] [Abstract][Full Text] [Related]
18. Direct interaction of Na-azide with the KATP channel.
Trapp S; Ashcroft FM
Br J Pharmacol; 2000 Nov; 131(6):1105-12. PubMed ID: 11082117
[TBL] [Abstract][Full Text] [Related]
19. The interaction of nucleotides with the tolbutamide block of cloned ATP-sensitive K+ channel currents expressed in Xenopus oocytes: a reinterpretation.
Gribble FM; Tucker SJ; Ashcroft FM
J Physiol; 1997 Oct; 504 ( Pt 1)(Pt 1):35-45. PubMed ID: 9350615
[TBL] [Abstract][Full Text] [Related]
20. Potent and selective activation of the pancreatic beta-cell type K(ATP) channel by two novel diazoxide analogues.
Dabrowski M; Larsen T; Ashcroft FM; Bondo Hansen J; Wahl P
Diabetologia; 2003 Oct; 46(10):1375-82. PubMed ID: 12961066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
